News
OncoZenge Provides Market and Strategy UpdateOncoZenge AB (publ) (“OncoZenge” or “the Company”) today announced a comprehensive market and strategy update after successfully securing full funding for ...
OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced a comprehensive market and strategy update after successfully securing full funding for its BupiZenge Phase 3 clinical trial aimed at ...
Texas Lawyer and Law.com are proud to announce the finalists and winners of the 2025 Texas Legal Awards. Congratulations, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback